EUROPE HORMONE REPLACEMENT THERAPY MARKET 2021-2028
TABLE OF CONTENTS
1. EUROPE HORMONE REPLACEMENT THERAPY
MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON HORMONE
REPLACEMENT THERAPY MARKET
2.2. KEY INSIGHTS
1.1.1. INTRODUCTION OF NEW DRUG DELIVERY
SYSTEMS FOR HORMONE REPLACEMENT
1.1.2. MODERN SEDENTARY LIFESTYLES
1.2. PORTER’S FIVE FORCES MODEL
1.1.1. THREAT OF NEW ENTRANTS
1.1.2. THREAT OF SUBSTITUTE PRODUCTS
1.1.3. BARGAINING POWER OF BUYERS
1.1.4. BARGAINING POWER OF SUPPLIERS
1.1.5. COMPETITIVE RIVALRY
1.2. MARKET ATTRACTIVENESS INDEX
1.3. VENDOR SCORECARD
1.4. KEY STRATEGIC DEVELOPMENTS
1.1.1. ACQUISITIONS & MERGERS
1.1.2. PRODUCT LAUNCH & DEVELOPMENTS
1.1.3. CONTRACTS AND PARTNERSHIPS
1.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS,
& DIVESTITURES
1.2. MARKET DRIVERS
1.1.1. RISE IN AWARENESS PERTAINING TO
HEALTH PROBLEMS DURING MENOPAUSE
1.1.2. INCREASE IN PREVALENCE OF HORMONAL
DISORDERS
1.1.3. NEW PRODUCT LAUNCHES BY MAJOR GIANTS
1.2. MARKET RESTRAINTS
1.1.1. HIGH COST OF TREATMENT
1.1.2. ADVERSE REACTIONS ASSOCIATED WITH
HORMONE REPLACEMENT THERAPY
1.2. MARKET OPPORTUNITIES
1.1.1. AVAILABILITY OF ALTERNATIVE THERAPY
OFFERS OPPORTUNITIES FOR THE MARKET’S GROWTH
1.1.2. LAUNCH OF TELEMEDICINE CLINICAL
PRACTICE SERVICES
2. EUROPE HORMONE REPLACEMENT THERAPY
MARKET - BY THERAPY TYPE
2.1. ESTROGEN HORMONE REPLACEMENT THERAPY
2.2. THYROID HORMONE REPLACEMENT THERAPY
2.3. TESTOSTERONE HORMONE REPLACEMENT
THERAPY
2.4. HUMAN GROWTH HORMONE REPLACEMENT
THERAPY
2.5. PROGESTOGEN HORMONE REPLACEMENT
THERAPY
3. EUROPE HORMONE REPLACEMENT THERAPY
MARKET - BY TYPE OF DISEASE
3.1. MENOPAUSE
3.2. MALE HYPOGONADISM
3.3. GROWTH HORMONE DEFICIENCY
3.4. HYPOTHYROIDISM
3.5. OTHER TYPE OF DISEASES
4. EUROPE HORMONE REPLACEMENT THERAPY
MARKET - BY ROUTE OF ADMINISTRATION
4.1. ORAL
4.2. PARENTERAL
4.3. TRANSDERMAL
4.4. OTHER ROUTES OF ADMINISTRATION
5. EUROPE HORMONE REPLACEMENT THERAPY
MARKET – COUNTRY OUTLOOK
5.1. GERMANY
5.2. FRANCE
5.3. UNITED KINGDOM
5.4. ITALY
5.5. RUSSIA
5.6. SPAIN
5.7. REST OF EUROPE
6. COMPETITIVE LANDSCAPE
1.1. ABBOTT LABORATORIES
1.2. AMGEN
1.3. ANI PHARMACEUTICALS
1.4. BAYER AG
1.5. DR REDDY’S LABORATORIES LTD
1.6. ELI LILLY & COMPANY
1.7. GENENTECH INC
1.8. IPSEN
1.9. MERCK KGAA
1.10.
NOVARTIS AG
1.11.
NOVEN PHARMACEUTICALS INC
1.12.
NOVO NORDISK A/S
1.13.
PFIZER INC
1.14.
TEVA PHARMACEUTICAL INDUSTRIES LTD
1.15.
VIATRIS INC (MYLAN NV)
2. RESEARCH METHODOLOGY & SCOPE
2.1. RESEARCH SCOPE & DELIVERABLES
1.1.1. OBJECTIVES OF STUDY
1.1.2. SCOPE OF STUDY
1.2. SOURCES OF DATA
1.1.1. PRIMARY DATA SOURCES
1.1.2. SECONDARY DATA SOURCES
1.2. RESEARCH METHODOLOGY
1.1.1. EVALUATION OF PROPOSED MARKET
1.1.2. IDENTIFICATION OF DATA SOURCES
1.1.3. ASSESSMENT OF MARKET DETERMINANTS
1.1.4. DATA COLLECTION
1.1.5.
DATA VALIDATION & ANALYSIS
LIST OF TABLES
TABLE 1: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF ACQUISITIONS
& MERGERS
TABLE 4: LIST OF PRODUCT
LAUNCHES & DEVELOPMENTS
TABLE 5: LIST OF CONTRACTS AND
PARTNERSHIPS
TABLE 6: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 7: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2021-2028 (IN $ MILLION)
TABLE 8: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2021-2028 (IN $ MILLION)
TABLE 9: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (IN $ MILLION)
LIST OF FIGURES
FIGURE 1: EUROPE HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 2: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2020 & 2028 (IN %)
FIGURE 3: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY ESTROGEN HORMONE REPLACEMENT THERAPY, 2021-2028
(IN $ MILLION)
FIGURE 4: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY THYROID HORMONE REPLACEMENT THERAPY, 2021-2028
(IN $ MILLION)
FIGURE 5: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY TESTOSTERONE HORMONE REPLACEMENT THERAPY,
2021-2028 (IN $ MILLION)
FIGURE 6: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY HUMAN GROWTH HORMONE REPLACEMENT THERAPY,
2021-2028 (IN $ MILLION)
FIGURE 7: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY PROGESTOGEN HORMONE REPLACEMENT THERAPY,
2021-2028 (IN $ MILLION)
FIGURE 8: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2020 & 2028 (IN %)
FIGURE 9: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY MENOPAUSE, 2021-2028 (IN $ MILLION)
FIGURE 10: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY MALE HYPOGONADISM, 2021-2028 (IN $ MILLION)
FIGURE 11: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY GROWTH HORMONE DEFICIENCY, 2021-2028 (IN $
MILLION)
FIGURE 12: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY HYPOTHYROIDISM, 2021-2028 (IN $ MILLION)
FIGURE 13: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY OTHER TYPE OF DISEASES, 2021-2028 (IN $ MILLION)
FIGURE 14: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2020 & 2028 (IN %)
FIGURE 15: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY ORAL, 2021-2028 (IN $ MILLION)
FIGURE 16: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY PARENTERAL, 2021-2028 (IN $ MILLION)
FIGURE 17: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY TRANSDERMAL, 2021-2028 (IN $ MILLION)
FIGURE 18: EUROPE HORMONE
REPLACEMENT THERAPY MARKET, BY OTHER ROUTES OF ADMINISTRATION, 2021-2028 (IN $
MILLION)
FIGURE 19: GERMANY HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 20: FRANCE HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 21: UNITED KINGDOM HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 22: ITALY HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 23: RUSSIA HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 24: SPAIN HORMONE REPLACEMENT
THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 25: REST OF EUROPE HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
Triton Market Research’s report estimated that the European hormone
replacement therapy market would witness growth at a compound annual growth
rate of 7.65% during 2021-2028. Spain, Russia, the United Kingdom, Italy,
France, Germany, and Rest of Europe shape the market in this region.
In the United Kingdom, the market for hormone replacement therapy is
driven mainly by the new drug initiatives undertaken by major market players.
For instance, Gedeon Richer launched Vagirux for treating vaginal atrophy due
to estrogen deficiency during the postmenopausal phase in 2020. Furthermore,
estrogen replacement and growth hormone replacement are two treatments that are
considered to be beneficial across the country. Besides, the National Institute
for Health and Care Excellence highly recommends growth hormone replacement
therapy for children suffering from poor health. Hence, all these factors are
offering lucrative opportunities to the hormone replacement therapy market in
the UK.
Earlier, Pharmasyntez announced the construction of the largest
production facility for hormonal drugs in Russia, adding to the growth of the
reviewed market. Moreover, the main application areas of these hormonal drugs
will be for contraception, hormone replacement, and gynecological diseases.
Also, as per media reports, transgender people in the country are needed to
undergo a psychiatric evaluation to obtain an F64.0 diagnosis, which will
authorize hormonal treatment and gender reassignment surgeries. Therefore, such
developments are likely to supplement the development of the Russian hormone
replacement therapy market.
COMPETITIVE OUTLOOK
The prominent players thriving in the hormone replacement therapy market
are Novo Nordisk A/S, Amgen, Pfizer Inc, Viatris Inc (Mylan NV), Bayer AG,
Merck KGAA, and Novartis AG.
Get more insights into the Europe Hormone Replacement Therapy Market:
https://www.tritonmarketresearch.com/reports/europe-hormone-replacement-therapy-market
SEGMENTATION
1. ABBOTT LABORATORIES
2. AMGEN
3. ANI PHARMACEUTICALS
4. BAYER AG
5. DR REDDY’S LABORATORIES LTD
6. ELI LILLY & COMPANY
7. GENENTECH INC
8. IPSEN
9. MERCK KGAA
10. NOVARTIS AG
11. NOVEN PHARMACEUTICALS INC
12. NOVO NORDISK A/S
13. PFIZER INC
14. TEVA PHARMACEUTICAL INDUSTRIES LTD
15.
VIATRIS INC (MYLAN NV)
Comments
Post a Comment